PIRS Pieris Pharmaceuticals Inc Yalpi foyda normasi

Pieris (PIRS) korporativ emblemasi va logotipi

Tushumning foiz ko'rsatkichi sifatidagi yalpi foyda samaradorlik dinamikasini namoyish etadi, bunda 0.00 qiymati Pieris Pharmaceuticals (PIRS) uchun ushbu metrikaning muvozanatini aks ettiradi. Biznes modeli ishlab chiqarish xarajatlarini minimallashtirish uchun protein litsenziyalashiga tayanadi. Biroq, likvidlik yetishmovchiligi va kapitalning sarflanishi ishlanmalarni murakkablashtiradi. Barqarorlik Anticalin platformasi ishlanmalari hamda onkologiyaga qarshi kurashish uchun AQSh va Germaniyadagi sog'liqni saqlash gigantlari bilan hamkorlik orqali ta'minlanadi.

PIRS Pieris Pharmaceuticals, Inc. Yalpi rentabellik (04.07.2022 - 20.11.2026)

Pieris (PIRS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Pieris Pharmaceuticals Inc tomonidan chiqariladigan mahsulotlar

Yalpi marja bevosita ishlab chiqarish xarajatlarini qoplashdan keyin qolgan tushum qismini belgilaydi va operatsion samaradorlikning fundamental ko'rsatkichi bo'lib xizmat qiladi. Ushbu metrikani yalpi foyda marjasi tendentsiyalari orqali tahlil qilish biznesning ma'muriy xarajatlarni hisobga olguncha foyda keltirish qobiliyatini baholash imkonini beradi. Pieris Pharmaceuticals (PIRS) uchun ushbu ko'rsatkich astma va onkologiya terapiyasi sherikliklari doirasidagi anti-kalin ishlanmalarining tijorat qiymatini aks ettiradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Ligand Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik Amneal AMRX|Sotuvning yalpi marjinal rentabelligi Perrigo Company PLC|Alvotech Biopharmaceuticals - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Yalpi rentabellik|anipharmaceuticals.com - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik MNKD|AMPH: Yalpi foyda normasi|Yalpi rentabellik pacira.com (PCRX)|Yalpi marja ARS Pharma (SPRY)|Theravance Biopharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Tectonic Therapeutic|TNXP: Yalpi marja|SXT China (SXTC) - Yalpi marja|Yalpi rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Invizyne (EXOZ)|ORMP - Yalpi foyda marjasi|Yalpi marja ENTX (Entera Bio)|Sotuvning yalpi marjinal rentabelligi MindWalk Therapeutics|ABVC: Yalpi foyda bo'yicha rentabellik|CPIX - Yalpi marja|QNTM (Quantum BioPharma) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha marjinallik FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Yalpi marja|Yalpi marja ranitherapeutics.com|Yalpi rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Sotuvning yalpi rentabelligi|lexariabioscience.com - Yalpi foyda bo'yicha rentabellik|Yalpi marja Pulmatrix Inc PULM|Pheton Holdings - Yalpi marja|Yalpi foyda bo'yicha marjinallik APM|Lyra Therapeutics, Inc. (LYRA) - Yalpi rentabellik|Yalpi foyda marjasi Impact BioMedical, Inc. (IBO)|Yalpi rentabellik TNF Pharma|YCBD: Yalpi foyda normasi|Yalpi marja PRFX|CYTO - Yalpi foyda marjasi|Yalpi rentabellik Lipella LIPO|Yalpi foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PROC - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja